Stocks
Denali Therapeutics (DNLI) ROA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| ROA, % | ? | -20.7% | -22.3% | -12.6% | -30.8% | -44.8% | -40.1% | |
| Changes by years, y/y, % | -25pp | -2pp | +10pp | -18pp | -14pp | |||
Denali Therapeutics. ROA, %
Denali Therapeutics. ROA, changes, pp
Denali Therapeutics (DNLI) ROA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| ROA, % | ? | -41.1% | -47.2% | -44.8% | -40.1% | -44.2% | -40.1% | |
| Changes by years, y/y, % | -13pp | -18pp | -14pp | -4pp | -3pp | |||
| Changes by quarters, q/q, % | -5pp | -6pp | +2pp | +5pp | -4pp | |||
